Meet DKSH at CPHI Milan 2026: Trusted in Pharma, Driven by Solutions

 

Join DKSH at CPHI Milan 2026 and discover our comprehensive portfolio of pharmaceutical and biopharmaceutical solutions supporting drug development and manufacturing from formulation through synthesis and commercial production.

 

As a trusted global partner, DKSH connects pharmaceutical and biopharma companies with high-quality ingredients, technical expertise, and resilient supply chains to accelerate innovation and bring therapies to market with confidence.

DKSH provides a multi-principal portfolio of pharmaceutical excipients for solid, liquid, and semisolid formulations. From binders and coating agents to solubilizers, stabilizers, and antioxidants, our solutions are backed by multi-compendial quality standards (Ph. Eur., USP-NF, JP) and a robust global supply network. Check out our Portfolio

Intermediates

DKSH sources advanced intermediates, reagents, and process materials across multiple synthesis pathways:

• Small Molecule API Synthesis – from early building blocks to complex late-stage intermediates, supporting R&D, scale-up, and commercial manufacturing.

• Peptide Synthesis – Fmoc amino acids, coupling reagents, resins, and linkers supporting the synthesis of peptide therapeutics, including GLP-1 applications.

• Oligonucleotide Synthesis – nucleosides, phosphoramidites, and derivatives supporting the synthesis of oligonucleotide-based therapeutics.

 

Whatever your target molecule — small molecule, peptide, or oligonucleotide — we help simplify sourcing and secure reliable supply across the full synthesis workflow.

Active Pharmaceutical Ingredients (APIs)

DKSH offers a broad multi-principal portfolio of Active Pharmaceutical Ingredients, sourced from qualified manufacturers and backed by full regulatory documentation, including CEP, DMF, and GMP certifications. From established generics to complex, high-potency molecules, we support pharmaceutical manufacturers with reliable supply, technical and regulatory expertise, and consistent quality across every batch — helping you move from formulation to commercial production with confidence.

DKSH offers GMP and non-GMP raw materials supporting every stage of biopharmaceutical development and manufacturing, including:

1. Bioprocessing Chemical Ingredients – acids, denaturants, solvents, amino acids

2. Cell Culture Media & Growth Factors – media, recombinant proteins, and supplements

3. mRNA Solutions – nucleosides, enzymes, and derivatives

4. Biocatalysis of APIs – enzyme libraries and screening kits

5. Oligonucleotides – nucleosides, phosphoramidites, and derivatives

6. ADC Solutions – PROTACs and advanced bioconjugation technologies

✔ Pharmaceutical excipients for solid, liquid, and semisolid formulations

✔ Small molecule synthesis intermediates and process materials

✔ Peptide synthesis solutions with GLP-1 expertise

✔ Biopharma materials for mRNA, oligonucleotides, ADCs, and cell culture applications

✔ Global sourcing, technical expertise, and resilient supply chains

 

Meet the DKSH pharmaceutical and biopharma experts at CPHI Milan 2026 to discuss how our portfolio can support your next formulation, synthesis, biologics, or advanced therapeutics project.